Manpreet K Singh - Building on the Science of Resilience

BrainMind Summit hosted at Stanford

Manpreet Singh, MD, MS

Associate Professor of Psychiatry and Behavioral Sciences, Stanford University
https://profiles.stanford.edu/manpree...

Dr. Singh is Associate Professor of Psychiatry and Behavioral Sciences, and Director of the Pediatric Mood Disorders Program in the Division of Child and Adolescent Psychiatry at Stanford. Her time is divided among the clinical, research, and teaching missions of department. She directs Stanford’s Pediatric Mood Disorders Program, which is an integrated multidisciplinary clinic that aims to treat youth with a spectrum of mood disorders along a developmental continuum. She leads a team of child and adolescent psychiatrists, psychologists, child and adolescent psychiatry fellows, clinical and research postdoctoral fellows, residents, medical students, and research coordinators. Her research focuses on investigating the origins and pathways for developing mood disorders during childhood, as well as methods to protect and preserve function before and after the onset of early mood problems.

Dr. Singh’s research team (Pediatric Emotion And Resilience Lab) conducts innovative research examining the neural, cognitive, and genetic underpinnings of pediatric mood disorders. She has extensive experience with multi-level investigations involving children and families, as well as clinical, neuroimaging, and dimensionally-based behavioral assessments. She completed her NIMH career development award that characterizes emotion regulation in healthy offspring of parents with bipolar disorder, and has been leading three independent NIMH funded studies examining the mechanisms of mood and other psychiatric disorders and their treatments among youth. She is extensively involved in collaborations aimed to investigate methods of treating problems associated with and leading up to mood disorders in youth. Specifically, she is examining the benefits of family focused psychotherapy, mindfulness meditation, and medications in youth with or at risk for mood disorders to reduce mood symptoms and family stress. She has also been reviewing the neural effects of medication and psychotherapy in youth. These areas of research hold considerable promise to impact our understanding of the core mechanisms and early interventions for pediatric onset mood disorders.